Literature DB >> 4630486

Experience with nifurtimox in chronic Chagas' infection. Preliminary report.

D H Wegner, R W Rohwedder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4630486

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  6 in total

Review 1.  Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.

Authors:  Juan Carlos Villar; Juan Guillermo Perez; Olga Lucia Cortes; Adelina Riarte; Micah Pepper; Jose Antonio Marin-Neto; Gordon H Guyatt
Journal:  Cochrane Database Syst Rev       Date:  2014-05-27

2.  Susceptibility of an insect Leptomonas and Crithidia fasciculata to several established antitrypanosomatid agents.

Authors:  J Bacchi; C Lambros; B Goldberg; S H Hutner; G D de Carvalho
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

3.  Nifurtimox-induced alterations in the cell-mediated immune response to PPD tin guinea-pigs.

Authors:  R Lelchuk; R L Cardoni; S Levis
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

4.  Cell-mediated immunity in Chagas' disease: Alterations induced by treatment with a trypanocidal drug (nifurtimox).

Authors:  R Lelchuk; R L Cardoni; A S Fuks
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

Review 5.  Drug repurposing and human parasitic protozoan diseases.

Authors:  Katherine T Andrews; Gillian Fisher; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-03-24       Impact factor: 4.077

6.  Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine.

Authors:  Michael Du; Linna Zhang; Kathleen A Scorsone; Sarah E Woodfield; Peter E Zage
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.